Chart Industries (NYSE:GTLS – Get Free Report) updated its FY25 earnings guidance on Friday. The company provided EPS guidance of $12.00-13.00 for the period, compared to the consensus estimate of $12.60. The company issued revenue guidance of $4.65-4.85 billion, compared to the consensus revenue estimate of $4.85 billion. Chart Industries also updated its FY 2024 guidance to 9.000-9.000 EPS.
Chart Industries Trading Up 5.7 %
GTLS traded up $7.38 during trading on Monday, reaching $137.38. 1,678,153 shares of the stock traded hands, compared to its average volume of 628,963. The stock has a market capitalization of $5.88 billion, a PE ratio of 39.68, a P/E/G ratio of 0.56 and a beta of 1.71. Chart Industries has a 12 month low of $101.60 and a 12 month high of $171.68. The stock’s 50-day moving average is $121.62 and its 200 day moving average is $136.98. The company has a quick ratio of 0.98, a current ratio of 1.27 and a debt-to-equity ratio of 1.28.
Chart Industries (NYSE:GTLS – Get Free Report) last posted its earnings results on Friday, November 1st. The industrial products company reported $2.18 EPS for the quarter, missing the consensus estimate of $2.56 by ($0.38). Chart Industries had a return on equity of 12.27% and a net margin of 2.80%. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the previous year, the firm earned $1.28 earnings per share. The company’s revenue was up 18.3% on a year-over-year basis. Equities analysts anticipate that Chart Industries will post 9.94 earnings per share for the current year.
Analyst Upgrades and Downgrades
View Our Latest Stock Analysis on GTLS
Insiders Place Their Bets
In other Chart Industries news, CEO Jillian C. Evanko purchased 440 shares of Chart Industries stock in a transaction dated Thursday, September 5th. The shares were acquired at an average cost of $114.31 per share, with a total value of $50,296.40. Following the completion of the transaction, the chief executive officer now owns 125,448 shares in the company, valued at approximately $14,339,960.88. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CEO Jillian C. Evanko purchased 440 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were bought at an average cost of $114.31 per share, with a total value of $50,296.40. Following the transaction, the chief executive officer now owns 125,448 shares of the company’s stock, valued at approximately $14,339,960.88. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Paul E. Mahoney purchased 500 shares of the stock in a transaction that occurred on Wednesday, September 11th. The shares were purchased at an average cost of $106.55 per share, for a total transaction of $53,275.00. Following the completion of the acquisition, the director now directly owns 2,107 shares of the company’s stock, valued at $224,500.85. This represents a 0.00 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders bought 7,152 shares of company stock worth $482,278. 0.95% of the stock is currently owned by company insiders.
Chart Industries Company Profile
Chart Industries, Inc engages in the designing, engineering, and manufacturing of process technologies and equipment for the gas and liquid molecules in the United States and internationally. The company operates in four segments: Cryo Tank Solutions, Heat Transfer Systems, Specialty Products, and Repair, Service & Leasing.
See Also
- Five stocks we like better than Chart Industries
- How Can Investors Benefit From After-Hours Trading
- Intel: Is Now the Time to Be Brave?Â
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 10 Best Airline Stocks to Buy
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Chart Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chart Industries and related companies with MarketBeat.com's FREE daily email newsletter.